These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 23337790

  • 21. Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.
    Ye JJ, Liang SJ, Guo N, Li SL, Wu AM, Giannini S, Sachdev D, Yee D, Brünner N, Ikle D, Fujita-Yamaguchi Y.
    Horm Metab Res; 2003; 35(11-12):836-42. PubMed ID: 14710366
    [Abstract] [Full Text] [Related]

  • 22. Insulin-like growth factor-I receptor signaling blockade combined with radiation.
    Allen GW, Saba C, Armstrong EA, Huang SM, Benavente S, Ludwig DL, Hicklin DJ, Harari PM.
    Cancer Res; 2007 Feb 01; 67(3):1155-62. PubMed ID: 17283150
    [Abstract] [Full Text] [Related]

  • 23. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
    Li JC, Li R.
    Cancer Res; 2007 Sep 15; 67(18):8856-64. PubMed ID: 17875727
    [Abstract] [Full Text] [Related]

  • 24. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.
    Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blättler WA, Chittenden T, Singh R.
    Cancer Res; 2003 Aug 15; 63(16):5073-83. PubMed ID: 12941837
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
    Yue L, Wang Y, Wang H, Gao H, Liang J, Sui A, Xiang J, Zhou F, Xu C, Zhao W, Liang W, Yao R.
    Oncol Rep; 2012 Oct 15; 28(4):1453-60. PubMed ID: 22895605
    [Abstract] [Full Text] [Related]

  • 26. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
    Sakai K, Yuasa N, Tsukamoto K, Takasaki-Matsumoto A, Yajima Y, Sato R, Kawakami H, Mizuno M, Takayanagi A, Shimizu N, Nakata M, Fujita-Yamaguchi Y.
    J Biochem; 2010 Jun 15; 147(6):809-17. PubMed ID: 20147453
    [Abstract] [Full Text] [Related]

  • 27. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
    Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A.
    Clin Cancer Res; 1999 Jul 15; 5(7):1935-44. PubMed ID: 10430101
    [Abstract] [Full Text] [Related]

  • 28. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
    Remacle-Bonnet M, Garrouste F, Baillat G, Andre F, Marvaldi J, Pommier G.
    Am J Pathol; 2005 Sep 15; 167(3):761-73. PubMed ID: 16127155
    [Abstract] [Full Text] [Related]

  • 29. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920
    [Abstract] [Full Text] [Related]

  • 30. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
    Li H, Adachi Y, Yamamoto H, Min Y, Ohashi H, Ii M, Arimura Y, Endo T, Lee CT, Carbone DP, Imai K, Shinomura Y.
    Cancer; 2011 Jul 15; 117(14):3135-47. PubMed ID: 21264842
    [Abstract] [Full Text] [Related]

  • 31. Differential mechanisms of acquired resistance to insulin-like growth factor-i receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model.
    Huang F, Hurlburt W, Greer A, Reeves KA, Hillerman S, Chang H, Fargnoli J, Graf Finckenstein F, Gottardis MM, Carboni JM.
    Cancer Res; 2010 Sep 15; 70(18):7221-31. PubMed ID: 20807811
    [Abstract] [Full Text] [Related]

  • 32. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
    Goetsch L, Gonzalez A, Leger O, Beck A, Pauwels PJ, Haeuw JF, Corvaia N.
    Int J Cancer; 2005 Jan 10; 113(2):316-28. PubMed ID: 15386423
    [Abstract] [Full Text] [Related]

  • 33. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H, Pelzer AM, Kiang DT, Yee D.
    Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722
    [Abstract] [Full Text] [Related]

  • 34. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D, Patil S, Li W, Humphrey LE, Brattain MG, Howell GM.
    Oncogene; 2002 Apr 25; 21(18):2785-96. PubMed ID: 11973637
    [Abstract] [Full Text] [Related]

  • 35. Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.
    Motallebnezhad M, Younesi V, Aghebati-Maleki L, Nickho H, Safarzadeh E, Ahmadi M, Movassaghpour AA, Hosseini A, Yousefi M.
    Tumour Biol; 2016 Nov 25; 37(11):14841-14850. PubMed ID: 27639384
    [Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC.
    J Am Coll Surg; 1995 Aug 25; 181(2):145-54. PubMed ID: 7627387
    [Abstract] [Full Text] [Related]

  • 37. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS, Kim SY, Arunachalam S, Hwang PH, Yi HK, Nam SY, Lee DY.
    Biochem Biophys Res Commun; 2009 Jul 17; 385(1):38-43. PubMed ID: 19427836
    [Abstract] [Full Text] [Related]

  • 38. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
    Garrouste FL, Remacle-Bonnet MM, Lehmann MM, Marvaldi JL, Pommier GJ.
    Endocrinology; 1997 May 17; 138(5):2021-32. PubMed ID: 9112401
    [Abstract] [Full Text] [Related]

  • 39. Renewed interest in basic and applied research involving monoclonal antibodies against an oncofetal Tn-antigen.
    Fujita-Yamaguchi Y.
    J Biochem; 2013 Aug 17; 154(2):103-5. PubMed ID: 23740330
    [Abstract] [Full Text] [Related]

  • 40. Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.
    Li SL, Liang SJ, Guo N, Wu AM, Fujita-Yamaguchi Y.
    Cancer Immunol Immunother; 2000 Jul 17; 49(4-5):243-52. PubMed ID: 10941907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.